v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   147,484,280      
Beginning balance at Dec. 31, 2024 $ 197,394 $ 1 $ 1,002,390 $ (11) $ (804,986)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 19,661   19,661    
Exercise of stock options (in shares)   148,557      
Exercise of stock options 36   36    
Vesting of restricted stock units (in shares)   1,554,329      
Shares withheld related to net share settlement of equity awards (in shares)   (702,060)      
Shares withheld related to net share settlement of equity awards (5,957)   (5,957)    
Other comprehensive loss (4)     (4)  
Net loss (1,771)       (1,771)
Ending balance (in shares) at Mar. 31, 2025   148,485,106      
Ending balance at Mar. 31, 2025 209,359 $ 1 1,016,130 (15) (806,757)
Beginning balance (in shares) at Dec. 31, 2025   145,050,642      
Beginning balance at Dec. 31, 2025 210,461 $ 1 1,011,477 162 (801,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 17,269   17,269    
Exercise of stock options (in shares)   3,750      
Vesting of restricted stock units (in shares)   1,453,518      
Shares withheld related to net share settlement of equity awards (in shares)   (570,789)      
Shares withheld related to net share settlement of equity awards (2,803)   (2,803)    
Other comprehensive loss (135)     (135)  
Net loss (12,614)       (12,614)
Ending balance (in shares) at Mar. 31, 2026   145,937,121      
Ending balance at Mar. 31, 2026 $ 212,178 $ 1 $ 1,025,943 $ 27 $ (813,793)